South San Francisco, CA · Founded 2024 · Privately Held (backing)
Developer of innovative therapeutics designed to treat immune-mediated diseases by targeting underlying immune system dysfunction. Ouro Medicines is based in South San Francisco, CA and was founded in 2024. Its last reported valuation was $1.7 billion in Mar 2026. It has raised $120 million.
Last reported valuation
$1.7B
Oct 2026
Priced at
—
Total raised
$120.0M
Last round
—
Team — not yet on record
No current team members for Ouro Medicines are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ouro Medicines with a free account
·Watch Ouro Medicines: the Monday email on marks, rounds and moves
